1110065P20Riktm1(KOMP)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
1110065P20Riktm1(KOMP)Wtsi |
| Name: |
RIKEN cDNA 1110065P20 gene; targeted mutation 1, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:4362621 |
| Gene: |
1110065P20Rik Location: Chr4:124743284-124744479 bp, - strand Genetic Position: Chr4, 57.92 cM
|
| IMPC: |
1110065P20Rik gene page |
|
| Mutant Cell Lines: |
EPD0321_6_A05, EPD0321_6_A08, EPD0321_6_B05, EPD0321_6_B08, EPD0321_6_C08, EPD0321_6_D05, EPD0321_6_D06, EPD0321_6_D07, EPD0321_6_E06, EPD0321_6_E08, EPD0321_6_F07, EPD0321_6_F08, EPD0321_6_G05, EPD0321_6_G06, EPD0321_6_H06 |
| Germline Transmission: |
Unknown
|
| Parent Cell Line: |
JM8A1.N3 (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
| Project Collection: |
KOMP-CSD
|
|
| Allele Type: |
|
Targeted (Null/knockout, Reporter) |
| Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 642 starting at position 124743596 and ending at position 124744238 of Chromosome 4 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:148605, J:173534)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 1 line available
|
| Carrying any 1110065P20Rik Mutation: |
4 strains or lines available
|
|
| Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
| All: |
2 reference(s) |
|
Analysis Tools
